Systematic review / meta-analysis / 2022
Daily vitamin D supplementation reduced cancer mortality overall and cancer incidence specifically in normal-weight individuals.
A meta-analysis evaluated RCTs to assess whether vitamin D dosing strategies and adiposity affect total cancer outcomes. Across 12 trials, vitamin D supplementation did not reduce total cancer incidence overall (SRR 0.99, 95% CI 0.94-1.03), though daily dosing showed an inverse association among normal-weight individuals (SRR 0.76, 95% CI 0.64-0.90) but not overweight/obese participants. For total cancer mortality (6 trials), the overall SRR was 0.92 (95% CI 0.82-1.03), but daily supplementation significantly reduced mortality (SRR 0.87, 95% CI 0.78-0.96) while infrequent large-bolus dosing did not.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- Participants across 12 RCTs for incidence and 6 RCTs for mortality
- What was measured
- Total cancer incidence and total cancer mortality
THE PAPER
Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials.
Keum N, Chen QY, Lee DH, Manson JE, Giovannucci E. Br J Cancer, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.